Beacon Pharmaceuticals PLC BEACONPHAR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 54.29
- Price/Sales
- 3.69
- Dividend Yield (Trailing)
- 1.07%
- Dividend Yield (Forward)
- 1.07%
- Total Yield
- 1.07%
Company Profile
Beacon Pharmaceuticals PLC manufactures and markets pharmaceutical products. Its products are used in various therapeutic areas, such as anticancer, cardiovascular, gastrointestinal, antibiotics, anti-coagulants, protein supplements, and muscle relaxants. The company exports its products to Europe, America, Australia, Africa, and Asia. The company's products can be segmented as General, Chronic Care, Oncology, and Biotech products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 3,872
- Website
- https://www.beaconpharma.com.bd
Comparables
Valuation
|
Metric
|
BEACONPHAR
|
ACMELAB
|
BXPHARMA
|
|---|---|---|---|
Price/Earnings (Normalized) | 54.29 | 5.70 | 9.69 |
Price/Book Value | 5.48 | 0.57 | 1.03 |
Price/Sales | 3.69 | 0.45 | 1.11 |
Price/Cash Flow | — | — | — |
Price/Earnings
BEACONPHAR
ACMELAB
BXPHARMA
Financial Strength
|
Metric
|
BEACONPHAR
|
ACMELAB
|
BXPHARMA
|
|---|---|---|---|
Quick Ratio | 0.39 | 0.21 | 0.70 |
Current Ratio | 1.22 | 1.10 | 1.80 |
Interest Coverage | 1.76 | 2.39 | 7.08 |
Quick Ratio
BEACONPHAR
ACMELAB
BXPHARMA
Profitability
|
Metric
|
BEACONPHAR
|
ACMELAB
|
BXPHARMA
|
|---|---|---|---|
Return on Assets (Normalized) | 4.32% | 4.71% | 7.64% |
Return on Equity (Normalized) | 10.35% | 10.25% | 11.97% |
Return on Invested Capital (Normalized) | 9.14% | 9.26% | 10.74% |
Return on Assets
BEACONPHAR
ACMELAB
BXPHARMA
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| Gwtxryyf | Lczhx | $81.1 Bil | |||
| Zoetis Inc Class A
ZTS
| Ylwxpcmppq | Svyw | $80.7 Bil | |||
| Haleon PLC ADR
HLN
| Nykplpkl | Kjlk | $38.6 Bil | |||
| Viatris Inc
VTRS
| Fzmfvpjp | Skwm | $12.5 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Ygswchlk | Shtyz | $12.1 Bil | |||
| Catalent Inc
CTLT
| Xjgnlrhv | Njkfmpz | $10.2 Bil | |||
| Perrigo Co PLC
PRGO
| Vyqvfgs | Fyfg | $3.7 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Gljvzyqk | Ybr | $3.4 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Tjvqzyk | Wxpvd | $3.3 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Qzmspgmkf | Gsmm | $2.9 Bil |